Background/Aims: In patients with phenylketonuria (PKU), target ranges of blood phenylalanine (Phe) concentrations have been tightened in order to improve long-term outcomes. We investigated day-to-day and week-to-week variations in blood Phe concentration and the effect of an additional Phe load. Methods: We performed a longitudinal study in 6 adult PKU patients. The study was divided in five 7-day periods: 1 period without any intervention (period I) and 4 periods with a Phe load on day 3 equivalent to 100% (periods II and III) and to 200% (periods IV and V) of each patient’s individual daily Phe intake. Phe loading was given as encapsulated L-Phe. Blood spots to measure blood Phe concentration were taken each morning before breakfast in all periods. Results: Day-to-day and week-to-week blood Phe concentrations varied considerably with and without intervention in Phe intake. Equal loads of Phe did not result in comparable effects in blood Phe concentrations in all patients. In periods II–IV, mean blood Phe concentrations of days 1–3 (pre-load) were not significantly different from days 4–7 (post-load). The 200% load resulted in a significantly larger variation. Conclusion: These results showed that patients with well-controlled PKU can incidentally tolerate 100% – and in some cases 200% – of their normal daily Phe intake.

Keywords:
Phenylketonuria, Phenylalanine, Blood phenylalanine concentration, Phenylalanine intake
1.
Walter JH, Lee PJ, Burgard P: Hyperphenylalaninaemia; in Fernandes J, Saudubray JM, van den Berghe G, Walter JH (eds): Inborn Metabolic Diseases, ed 4. Heidelberg, Springer, 2006, pp 221–232.
2.
van Spronsen FJ, Smit PG, Koch R: Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet. J Inherit Metab Dis 2001;24:1–4.
3.
Scriver CR, Kaufman S: Phenylalanine hydroxylase deficiency; in Scriver CR, Baudet A, Sly W, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, ed 8. New York, McGraw-Hill, 2001, vol II, pp 1667–1724.
4.
Shaw V, Lawson M: Clinical Paediatric Dietetics, ed 2. Oxford, Blackwell, 2001.
5.
Guttler F, Olesen ES, Wamberg E: Diurnal variations of serum phenylalanine in phenylketonuric children on low phenylalanine diet. Am J Clin Nutr 1969;22:1568–1570.
6.
Farquhar DL, Steven F, Westwood A: Preliminary report on inverse diurnal variation of phenylalanine: implications in maternal phenylketonuria. Hum Nutr Appl Nutr 1985;39:224–226.
7.
MacDonald A, Rylance GW, Asplin D, Hall SK, Booth IW: Does a single plasma phenylalanine predict quality of control in phenylketonuria? Arch Dis Child 1998;78:122–126.
8.
van Spronsen FJ, van Rijn M, van Dijk T, Smit GP, Reijngoud DJ, Berger R, Heymans HS: Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 1993;92:570–573.
9.
van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS: Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day. Pediatrics 1996;97:839–844.
10.
Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria. Arch Dis Child 1993;68:426–427.
11.
Darcy B: Availability of amino acids in monogastric animals. Variations of digestive origin. Diabete Metab 1984;10:121–133.
12.
Rerat A, Chayvialle JA, Kande J, Vaissade P, Vaugelade P, Bourrier T: Metabolic and hormonal effects of test meals with various protein contents in pigs. Can J Physiol Pharmacol 1985;63:1547–1559.
13.
Daenzer M, Petzke KJ, Bequette BJ, Metges CC: Whole-body nitrogen and splanchnic amino acid metabolism differ in rats fed mixed diets containing casein or its corresponding amino acid mixture. J Nutr 2001;131:1965–1972.
14.
Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA: Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 2002;40:7–15.
15.
MacDonald A, Rylance G, Hall SK, Asplin D, Booth IW: Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 1996;74:412–417.
16.
van Spronsen FJ, van Rijn M, van Dijk T, Smit GP, Reijngoud DJ, Berger R, Heymans HS: Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 1993;92:570–573.
17.
Langenbeck U, Zschocke J, Wendel U, Honig V: Modelling the phenylalanine blood level response during treatment of phenylketonuria. J Inherit Metab Dis 2001;24:805–814.
18.
MacLeod EL, Gleason ST, van Calcar SC, Ney DM: Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes. Mol Genet Metab 2009;98:331–337.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.